Alterity Therapeutics Limited (ASX:ATH)
Australia · Delayed Price · Currency is AUD 0.5450
+0.0150 (2.83%)
Jul 31, 2026, 3:55 PM AEST
Alterity Therapeutics Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Net Income | -14.59 | -12.15 | -19.12 | -13.81 | -12.85 | -15.31 |
Depreciation & Amortization | 0.13 | 0.14 | 0.15 | 0.1 | 0.05 | 0.08 |
Asset Writedown & Restructuring Costs | - | - | - | 0.01 | - | - |
Stock-Based Compensation | 2.4 | 0.98 | 0.88 | 0.97 | 1.51 | 1.88 |
Other Operating Activities | 0.28 | 0.19 | -0.26 | -0.92 | -2.81 | 0.43 |
Change in Accounts Receivable | -1.16 | 0.1 | 4.62 | -3.94 | -0.45 | -4.22 |
Change in Accounts Payable | -0.45 | -2.04 | 1.1 | -1.56 | 2.6 | 0.43 |
Change in Other Net Operating Assets | -0.32 | 1.33 | 0.02 | -0.89 | -0.39 | -0.62 |
Operating Cash Flow | -13.71 | -11.45 | -12.61 | -20.04 | -12.34 | -17.33 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Capital Expenditures | - | - | -0.01 | -0.01 | -0.09 | -0.01 |
Investment in Securities | - | -7.5 | - | - | - | - |
Other Investing Activities | - | - | - | -0.03 | - | - |
Investing Cash Flow | - | -7.5 | -0.01 | -0.04 | -0.09 | -0.01 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Long-Term Debt Repaid | - | -0.13 | -0.01 | -0.06 | -0.03 | -0.06 |
Net Debt Issued (Repaid) | -0.13 | -0.13 | -0.01 | -0.06 | -0.03 | -0.06 |
Issuance of Common Stock | 62.55 | 42.57 | 10.14 | 0.32 | 17.18 | 39.24 |
Other Financing Activities | -3.85 | -2.77 | -0.92 | -0.13 | -0.84 | -2.49 |
Financing Cash Flow | 58.57 | 39.67 | 9.22 | 0.12 | 16.3 | 36.69 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Foreign Exchange Rate Adjustments | -0.2 | -0.2 | 0.26 | 0.91 | 2.81 | -0.43 |
Net Cash Flow | 44.66 | 20.52 | -3.13 | -19.03 | 6.69 | 18.92 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Free Cash Flow | -13.71 | -11.45 | -12.61 | -20.04 | -12.43 | -17.34 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -206.62% | -210.54% | -313.78% | -511.78% | -242.54% | -399.59% |
Free Cash Flow Per Share | -0.08 | -0.09 | -0.17 | -0.41 | -0.26 | -0.51 |
Levered Free Cash Flow | -10.61 | -8.66 | -5.36 | -14.53 | -6.46 | -11.91 |
Unlevered Free Cash Flow | -10.61 | -8.66 | -5.36 | -14.53 | -6.46 | -11.91 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash Interest Paid | - | - | 0.01 | 0 | 0 | 0 |
Cash Income Tax Paid | - | -5.56 | -8.53 | 0.1 | -4.08 | - |
Change in Working Capital | -1.93 | -0.61 | 5.75 | -6.39 | 1.76 | -4.41 |